Anti-hypertension effects of traditional Chinese medicine Ju-Ling-Tang on renal hypertensive rats

American Journal of Chinese Medicine

Volumn 33, Issue 6, 2005, Pages 913-921

  Shih, Hung Che ^a,b,c   Lee, Tzu Hsin ^a   Chen, Shu Chen ^a   Li, Chien Ying ^b   Shibuya, Takeshi ^c  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Ah Jiao; Anti hypertension; Fu Ling; Ju Ling; Ju Ling Tang; Traditional Chinese medicine; Ze Hsieh

Indexed keywords

ALISMA PLANTAGO EXTRACT; ANTIHYPERTENSIVE AGENT; CHINESE DRUG; EQUUS ASINUS EXTRACT; GRIFOLA UMBELLATE EXTRACT; JU LING TANG; METHYLDOPA; NIFEDIPINE; PLANT EXTRACT; PORIA COCOS EXTRACT; UNCLASSIFIED DRUG;

ALISMA PLANTAGO; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTERY LIGATION; ARTICLE; BLOOD PRESSURE; CHINESE MEDICINE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; EQUUS ASINUS; GLOMERULOSCLEROSIS; GRIFOLA UMBELLATE; MALE; MEDICINAL PLANT; NONHUMAN; NOSE FEEDING; RAT; RENAL ARTERY; RENOVASCULAR HYPERTENSION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BIOPSY; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HYPERTENSION, RENAL; KIDNEY; MALE; METHYLDOPA; NIFEDIPINE; RATS; RATS, WISTAR;

EID: 31144476244     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X05003545     Document Type: Article

References (23)

1. Bakris, G.L., A. Mangrum, J.B. Copley, V. Nancy and S. Rebecca. Effect of calcium channel or β-blockade on the progression of diabetic nephropathy in Africans. Hypertension 29: 744-750, 1997.
2. Dworkin, L.D., H.D. Feinner and J. Randzzo. Glomerular hypertension and injury in desoxycorticosterone-salt rats on anti-hypertensive therapy. Kidney Int. 31: 718-734, 1987.
3. Dworkin, L.D., T.H. Hostetter, H.G. Rennke and B.M. Brenner. Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension. J. Clin. Invest. 73: 1448-1461, 1984.
4. Ernesto, L.S., S. Pavol, J.S. Li, T. Andre and T. Reudelhuber. Anti-hypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats. Br. J. Pharmacol. 115: 1377-1381, 1995.
5. Gavras, H., H.R. Brunner, J.H. Laragh, E.D. Vaughan, L.J. Cote and I. Gavras. Malignant hypertension resulting from deoxycorticosterone acetate and salt excess. Circ. Res. 36: 300-309, 1975.
6. Gradman, A.H. and C. Acevedo. Evolving strategies for the use of combination therapy in hypertension. Curr. Hypertens. Rep. 4(5): 343-349, 2002.
7. Health Statistics. Department of Health, Executive Yuan, Taiwan, R.O.C., 2002.
8. Heptinstall, R.H. and G.S. Hill. Steroid-induced hypertension in the rat: A study of the effects of renal artery constriction on hypertension caused by deoxycorticosterone. Lab. Invest. 16: 751-767, 1967.
9. Kretzler, M., K.H. Inge and W. Kriz. Podocyte damage is a critical step in the development of glomerulosclerosis in the uninephrectomised-desoxycorticosterone hypertensive rat. Virchows Arch. 425: 181-193, 1994.
10. Kuang, A.K. and L.S. Gong (eds.) Hypertension Research, 1st ed. Hu-Nan Technology Publishers, China, 1992a, pp. 54-57.
11. Kuang, A.K. and L.S. Gong (eds.) Hypertension Research, 1st ed. Hu-Nan Technology Publishers, China, 1992b, pp. 71-79.
12. Lee, R.M. Structural alterations of blood vessels in hypertensive rats. Can. Physiol. Pharmacol. 65(8): 1528-1535, 1987.
13. Quloobul, H. and M. Graham. Metabolic studies of uridine in rats with DOCA-salt hypertension and on high sodium diet. Clin. Exp. Pharmacol. Physiol. 20: 384-387, 1993.
14. - co-transport is a marker of distal tubular function in essential hypertension. J. Hypertens. 13: 1775-1778, 1995.
15. Safar, M.E., M.A.B. Lu and A.J. Hary. Resistance and conduit arteries following converting enzyme inhibition in hypertension. J. Vasc. Res. 34: 67-81, 1997.
16. Schwietzer, G. and K.H. Gertz. Changes of hemodynamics and glomerular ultrafiltration in renal hypertension of rats. Kidney Int. 15: 134-143, 1979.
17. Stili, W.J.S. and S.M. Dennison. The preparation of the glomerular changes in steroid-induce hypertension in rat. Lab. Invest. 20: 249-260, 1969.
18. Tijssen, J.G.P. Critical appraisal of recent studies on nifedipine and other calcium channel blockers in coronary artery disease and hypertension [correspondence]. Eur. Heart J. 17: 1152-1157, 1996.
19. Tng, U.-L. The Pharmacology and Applications of Chinese Medicine (Zhong Yi Fang Ji De Yao Li Yu Ying-Yong). 1st ed. Chongoine Publisher, China, 1990, pp. 453-455.
20. Wang, A. Medical Material Preparation (Ching Dynasty). Chi-Yuan Publishers, Taipei, 1988, p. 280.
21. Zheng, H.-Z., Z.H. Dong and J. She. Modern Study of Traditional Chinese Medicine Volume IV. Xue Yuan Press, Beijing, 1998a, p. 4167.
22. Zheng, H.-Z., Z.H. Dong and J. She. Modern Study of Traditional Chinese Medicine Volume IV. Xue Yuan Press, Beijing, 1998b, pp. 3114-3131.
23. Zheng, H.-Z., Z.H. Dong and J. She. Modern Study of Traditional Chinese Medicine Volume V. Xue Yuan Press, Beijing, 1998c, pp. 4939-4947.